NFKB1 and neoplasm: In addition, the use of NF-κB or STAT3 inhibitor decreased PD-L1 expression in adi-CM-treated tumor cells, which provided more evidence that TNF-α and/or IL-6 signaling mediated the regulation of PD-L1 in adi-CM-treated tumor cells.